Sort by
Refine Your Search
-
methodologies and overall research progress. Position Status Full Time Posting Number 26FA0670 Posting Open Date Posting Close Date 10/01/2026 Qualifications Minimum Education and Experience PhDs degree in life
-
conferences. Level of Decision Making: The postdoc will design and optimize experiments, particularly for Next Generation Sequencing workflows, including library preparation and data analysis. They will
-
applications. FLSA Exempt Grade Salary Details A minimum of $63,968 for calendar year appointments Minimum Salary 20,000 Mid Range Salary 90,000 Maximum Salary 200,000 Offer Information The final salary offer
-
/2026 Posting Close Date 08/02/2028 Qualifications Minimum Education and Experience A Ph.D. or Doctorate degree in a relevant research field is required. Knowledge of proteomics, protein purification
-
fears, we will engender hope for cancer patients and their families and play a critical role in strengthening the fabric of our communities by gaining and protecting their trust and providing access
-
range of techniques, including cognitive tasks administered in the lab and on smartphones, functional MRI (including densely sampled, precision imaging), and clinical assessment and phenotyping. By
-
the supervision of the AVP, manages and coordinates research projects. Prepares manuscripts summarizing the center’s research projects for submission to professional journals and publications. FLSA Exempt Grade
-
Education and Experience Ph.D. in Kinesiology, Physiology, Neuroscience, Neurology, Biomedical Science, Psychology, Rehabilitation Science, or a related discipline. Candidates in ABD (all but degree) status
-
discussion related to the involved research with the Principal Investigator, collaborating researchers, and laboratory members. FLSA Exempt Grade Salary Details A minimum of $63,968 for calendar year
-
hope for cancer patients and their families and play a critical role in strengthening the fabric of our communities by gaining and protecting their trust and providing access to the outstanding oncology